This may ultimately lead to resistance to EGFR inhibitors and an increase in VEGFR-2 expression.45,46 Consequently, simultaneous inhibition of both EGFR and VEGFR-2 has emerged as an effective cancer therapeutic method that operates synergistically.47–49. Here, KDR is linked to cancer.